{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T19:04:46Z","timestamp":1777143886087,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.arcped.2021.09.011","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T12:28:34Z","timestamp":1635164914000},"page":"696-701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of the effect of continuous intravenous infusion of sodium valproate and midazolam on management of status epilepticus in children"],"prefix":"10.1016","volume":"28","author":[{"given":"Ali","family":"Abbaskhanian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7075-2513","authenticated-orcid":false,"given":"Kobra","family":"Sheidaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamshid Yazdani","family":"Charati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salar","family":"Behzadnia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2021.09.011_bib0001","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus\u2013report of the ILAE task force on classification of status epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.arcped.2021.09.011_bib0002","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s40265-015-0454-2","article-title":"Pharmacotherapy for status epilepticus","volume":"75","author":"Trinka","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.arcped.2021.09.011_bib0003","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0140-6736(20)30611-5","article-title":"Efficacy of levetiracetam, fosphenytoin,and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial","volume":"395","author":"Chamberlain","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2021.09.011_bib0004","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/S0140-6736(19)30722-6","article-title":"Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial","volume":"393","author":"Dalziel","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2021.09.011_bib0005","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(19)30724-X","article-title":"Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial","volume":"393","author":"Lyttle","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2021.09.011_bib0006","series-title":"Textbook of pediatrics, international edition: 2-volume set","author":"Robert","year":"2019"},{"key":"10.1016\/j.arcped.2021.09.011_bib0007","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(06)69043-0","article-title":"Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study","volume":"368","author":"Chin","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2021.09.011_bib0008","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12098-010-0291-y","article-title":"Status epilepticus","volume":"78","author":"Raj","year":"2011","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.arcped.2021.09.011_bib0009","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.emc.2010.08.005","article-title":"Generalized convulsive status epilepticus in adults and children: treatment guidelines and protocols","volume":"29","author":"Shearer","year":"2011","journal-title":"Emerg Med Clinics"},{"key":"10.1016\/j.arcped.2021.09.011_bib0010","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.neurol.2008.11.009","article-title":"Prise en charge d'un \u00e9tat de mal \u00e9pileptique de l'enfant (nouveau-n\u00e9 exclu)","volume":"165","author":"Hubert","year":"2009","journal-title":"Rev Neurol"},{"key":"10.1016\/j.arcped.2021.09.011_bib0011","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1177\/0883073809332768","article-title":"Management of prolonged seizures and status epilepticus in childhood: a systematic review","volume":"24","author":"Sofou","year":"2009","journal-title":"J Child Neurol"},{"key":"10.1016\/j.arcped.2021.09.011_bib0012","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.seizure.2010.10.034","article-title":"Convulsive status epilepticus in children: etiology, treatment protocol and outcome","volume":"20","author":"Saz","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.arcped.2021.09.011_bib0013","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/01.wnl.0000180959.31355.92","article-title":"Treatment delay and the risk of prolonged status epilepticus","volume":"65","author":"Eriksson","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.arcped.2021.09.011_bib0014","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2165\/00023210-200519090-00003","article-title":"Refractory generalised convulsive status epilepticus","volume":"19","author":"K\u00e4lvi\u00e4inen","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.arcped.2021.09.011_bib0015","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ejpn.2012.01.012","article-title":"Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial","volume":"16","author":"Malamiri","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.arcped.2021.09.011_bib0016","first-page":"85","article-title":"Comparison of the effect of phenobarbital versus sodium valproate in management of children with status epilepticus","volume":"12","author":"Khajeh","year":"2018","journal-title":"Iran J Child Neurol"},{"key":"10.1016\/j.arcped.2021.09.011_bib0017","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/j.1528-1167.2007.01175.x","article-title":"The epidemiology of convulsive status epilepticus in children: a critical review","volume":"48","author":"Raspall-Chaure","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.arcped.2021.09.011_bib0018","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1046\/j.1528-1157.2003.41302.x","article-title":"Safety and efficacy of intravenous valproate inpediatric status epilepticus and acute repetitive seizures","volume":"44","author":"Yu","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.arcped.2021.09.011_bib0019","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1212\/WNL.54.11.2188-a","article-title":"Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus","volume":"54","author":"\u00dcberall","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.arcped.2021.09.011_bib0020","first-page":"359","article-title":"Status epilepticus in children experience with intravenous valproate. Update of treatment guidelines","volume":"29","author":"Campistol","year":"1999","journal-title":"Revista de Neurologia"},{"key":"10.1016\/j.arcped.2021.09.011_bib0021","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/01.wnl.0000224880.35053.26","article-title":"Sodium valproate vs phenytoin in status epilepticus: a pilot study","volume":"67","author":"Misra","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.arcped.2021.09.011_bib0022","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/adc.76.5.445","article-title":"Continuous midazolam infusion as treatment of status epilepticus","volume":"76","author":"Koul","year":"1997","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.arcped.2021.09.011_bib0023","first-page":"290","article-title":"[Efficacy of continuous intravenous infusion of midazolam in the treatment of status epilepticus in children]","volume":"30","author":"Minagawa","year":"1998","journal-title":"No To Hattatsu"},{"key":"10.1016\/j.arcped.2021.09.011_bib0024","first-page":"185","article-title":"Non-convulsive status epilepticus in children: clinical profile, EEG characteristics and treatment","volume":"27","author":"Fatema","year":"2018","journal-title":"Mymensingh Med J"},{"key":"10.1016\/j.arcped.2021.09.011_bib0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1212\/01.WNL.0000149527.47600.5A","article-title":"Efficacy of rapid IV administration of valproic acid for status epilepticus","volume":"64","author":"Limdi","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.arcped.2021.09.011_bib0026","first-page":"78","article-title":"The role of intravenous valproate in convulsive status epilepticus in the future","volume":"19","author":"Kwan","year":"2010","journal-title":"Acta Neurol Taiwan"},{"key":"10.1016\/j.arcped.2021.09.011_bib0027","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1177\/0883073807306248","article-title":"Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial","volume":"22","author":"Mehta","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1016\/j.arcped.2021.09.011_bib0028","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/088307380201700203","article-title":"Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus","volume":"17","author":"Singhi","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.arcped.2021.09.011_bib0029","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1007\/s00134-006-0362-8","article-title":"High-dose midazolam therapy for refractory status epilepticus in children","volume":"32","author":"Morrison","year":"2006","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.arcped.2021.09.011_bib0030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1212\/WNL.0000000000000054","article-title":"High-dose midazolam infusion for refractory status epilepticus","volume":"82","author":"Fernandez","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.arcped.2021.09.011_bib0031","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/j.1468-1331.2011.03420.x","article-title":"Valproate versus diazepam for generalized convulsive status epilepticus: a pilot study","volume":"18","author":"Chen","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.arcped.2021.09.011_bib0032","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.braindev.2010.04.003","article-title":"Pharmacokinetics and clinical application of intravenous valproate in Thai epileptic children","volume":"33","author":"Visudtibhan","year":"2011","journal-title":"Brain Dev"},{"key":"10.1016\/j.arcped.2021.09.011_bib0033","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-0404.2007.00847.x","article-title":"Valproate is an effective, well-tolerated drug for treatment of status epilepticus\/serial attacks in adults","volume":"115","author":"Olsen","year":"2007","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.arcped.2021.09.011_bib0034","first-page":"100","article-title":"Intravenous valproate for seizures in 137 Taiwanese children-valproate naive and non-naive","volume":"19","author":"Chang","year":"2010","journal-title":"Acta Neurol Taiwan"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X21001585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X21001585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:55:32Z","timestamp":1760540132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X21001585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0929693X21001585"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2021.09.011","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the effect of continuous intravenous infusion of sodium valproate and midazolam on management of status epilepticus in children","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2021.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}